Cho J, Ham W, Lee B, Kim H, Park J
Cancers (Basel). 2025; 17(5).
PMID: 40075695
PMC: 11898644.
DOI: 10.3390/cancers17050848.
Zacchi F, Sordo A, Torresan I, Lorenzi C, Tasselli E, Pafumi S
Front Oncol. 2025; 15:1532421.
PMID: 40061901
PMC: 11885129.
DOI: 10.3389/fonc.2025.1532421.
Su X, Tao Y, Chen F, Han X, Xue L
Sci Rep. 2025; 15(1):7655.
PMID: 40038504
PMC: 11880295.
DOI: 10.1038/s41598-025-92033-5.
Chen S, Zhang Y, Li X, Wang J, Li K, Wan S
Hereditas. 2025; 162(1):29.
PMID: 40016843
PMC: 11866615.
DOI: 10.1186/s41065-025-00384-w.
Liang W, Wang Z, Huang Z, Huang Y, Li C, Liang Y
Front Immunol. 2025; 16:1430673.
PMID: 40013152
PMC: 11860080.
DOI: 10.3389/fimmu.2025.1430673.
Spontaneous Necrosis of a High-Risk Bladder Tumor Under Immunotherapy for Concurrent Malignant Melanoma: Role of BRAF Mutations and PD-L1 Expression.
Condoiu C, Musta M, Cumpanas A, Bardan R, Dema V, Zara F
Biomedicines. 2025; 13(2).
PMID: 40002790
PMC: 11852637.
DOI: 10.3390/biomedicines13020377.
Impact of upper tract urothelial carcinoma history on patients with non-muscle invasive bladder cancer undergoing intravesical chemotherapy.
Ji J, Wang F, Lai C, Wang M, Hu H, Xu K
Sci Rep. 2025; 15(1):5977.
PMID: 39966479
PMC: 11836338.
DOI: 10.1038/s41598-025-89525-9.
Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review).
Wan X, Wang D, Zhang X, Xu M, Huang Y, Qin W
Int J Oncol. 2025; 66(3).
PMID: 39917986
PMC: 11837902.
DOI: 10.3892/ijo.2025.5724.
Blood lead levels and bladder cancer among US participants: NHANES 1999-2018.
Huang M, Li H, Chen J, Li L, Zhan Y, Du Y
BMC Public Health. 2025; 25(1):416.
PMID: 39894828
PMC: 11787758.
DOI: 10.1186/s12889-025-21549-2.
Development and Validation of a Competitive Risk Model in Elderly Patients with Transitional Cell Bladder Carcinoma.
Yang L, Chen C, Wang Q, Zhuang Z, Sun T
Med Sci Monit. 2025; 31:e946332.
PMID: 39876530
PMC: 11789422.
DOI: 10.12659/MSM.946332.
Successful Treatment of Non-invasive Bladder Cancer During Pregnancy: Diagnostic and Management Challenges.
Reddy Depa A, Reddy Beeravalli R, Bommiti A, Pawar S
Cureus. 2025; 16(12):e75417.
PMID: 39791033
PMC: 11711065.
DOI: 10.7759/cureus.75417.
Treatment of metastatic urothelial carcinoma in the United Kingdom, France, Germany, Italy, and Spain.
Hasaligil A, Munro V, Strunz-McKendry T, Wang-Silvanto J, Milloy N, Unsworth M
Future Oncol. 2025; 21(5):569-578.
PMID: 39789976
PMC: 11845109.
DOI: 10.1080/14796694.2024.2445498.
Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy.
Degerli E, Arslan C, Selcukbiricik F, Olmez O, Erdem D, Hamdard J
Medicina (Kaunas). 2025; 60(12.
PMID: 39768982
PMC: 11676646.
DOI: 10.3390/medicina60122103.
Anticancer potentials of chaga and notoginseng against dog bladder cancer organoids.
Shinohara Y, Elbadawy M, Liu Y, Yamanaka M, Yamamoto H, Sato Y
J Vet Med Sci. 2025; 87(2):232-240.
PMID: 39756955
PMC: 11830434.
DOI: 10.1292/jvms.24-0258.
HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy.
Tang Z, Qian Y, Wang N, Chen Y, Huang H, Zhang J
Int J Med Sci. 2025; 22(1):140-157.
PMID: 39744172
PMC: 11659835.
DOI: 10.7150/ijms.98334.
Predicting distant metastasis of bladder cancer using multiple machine learning models: a study based on the SEER database with external validation.
Zou X, Rao X, Huang J, Zhou J, Chao Chao H, Zeng T
Front Oncol. 2024; 14:1477166.
PMID: 39735606
PMC: 11681425.
DOI: 10.3389/fonc.2024.1477166.
Efficacy and safety of first-line immunotherapy-containing regimens compared with chemotherapy for advanced or metastatic urothelial carcinoma: a network meta-analysis of randomized controlled trials.
Liang W, Huang S, Huang Y, Huang M, Li C, Liang Y
Front Oncol. 2024; 14:1453338.
PMID: 39723374
PMC: 11668658.
DOI: 10.3389/fonc.2024.1453338.
Navigating the obesity paradox in bladder cancer prognosis-insights from the Taiwan National Health Insurance System Database.
Tseng W, Chiang T, Ho C, Huang S, Chiu A, Li C
Front Nutr. 2024; 11:1433632.
PMID: 39723162
PMC: 11669321.
DOI: 10.3389/fnut.2024.1433632.
The emerging role of long non-coding RNA SOX2-OT in cancers and non-malignant diseases.
Yang J, Tan F, Chen Y, Li X, Yuan C
J Physiol Biochem. 2024; .
PMID: 39702742
DOI: 10.1007/s13105-024-01059-2.
Potential role of TWIST1 and its methylation in bladder urothelial carcinoma.
Wan M, Meng H, Li H
Transl Cancer Res. 2024; 13(11):6070-6086.
PMID: 39697731
PMC: 11651768.
DOI: 10.21037/tcr-24-1029.